World Heart Day: experts demand urgent action on heart failure

News & Events

25 May 2016
AUTHOR: HFPN Admin

Representatives of the Heart Failure Policy Network secretariat were invited to join a panel of experts in cardiovascular disease as part of the World Heart Federation event for the 69th World Health Assembly in Geneva, Switzerland.

At the event, ‘Tackling CVD through Primary Health Care’, distinguished speakers included:

Chair and panellists discussed the significant gaps in patient access to health care services for cardiovascular disease at the primary health care level across the world, practical solutions that had been mounted to date, and outstanding challenges facing policy makers and health system leaders.

Speaking on behalf of the Members of the Heart Failure Policy Network, Ed Harding raised specific talking points on the need to provide accreditation for non-physician health workers and heart-specialist nurses as an example of much needed innovation and strategic preparedness in cardiovascular disease – which joined with many other calls to reinvent primary health care to meet pressing sustainability challenges.

Photos and discussion points were shared by on social media. To find out more, follow @worldheartfed and @hfpolicynetwork,  or the Heart Failure Policy Network’s campaign hashtag #changeHFpolicy.

Tagged:

More from News & Events

Strategic consensus on heart failure in Portugal launched
Strategic consensus on heart failure in Portugal launched...
06 October 2020
The HFPN has collaborated with the Institute of Health Sciences of the Catholic University of Portugal to develop a strategic consensus on heart failure in Portugal....
Read article
HFPN participates in Portuguese event on heart failure
HFPN participates in Portuguese event on heart failure...
24 January 2020
The HFPN attended the Annual Meeting of the Heart Failure Working Group of the Portuguese Society of Cardiology....
Read article
The Heart Failure Policy Network is made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.